Drug Type Small interfering RNA |
Synonyms RN0191 |
Target |
Mechanism PCSK9 inhibitors(Proprotein convertase subtilisin kexin type 9 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hypercholesterolemia | Phase 1 | AU | 14 Jul 2023 | |
Complex dyslipidemia | IND Approval | CN | 02 Jan 2024 | |
Primary hypercholesterolemia | IND Approval | CN | 02 Jan 2024 | |
Atherosclerosis | IND Application | AU | 22 May 2023 |